Physician profile
Ronny E Antelo
NPI 1508895483
$2,792.28
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $553 · 2021: $1,638 · 2022: $88.35.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $716.29 | 2019-2022 | |
| Ucb, INC. | $283.04 | 2019-2021 | |
| Genzyme Corporation | $279.99 | 2019-2021 | |
| Biogen, INC. | $245.80 | 2019-2021 | |
| Csl Behring | $209.98 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $209.59 | 2019-2021 | |
| Emd Serono, INC. | $126.38 | 2019-2020 | |
| Neurelis, INC. | $110.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $95.15 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $91.53 | 2020-2021 | |
| Amgen INC. | $79.73 | 2021 | |
| Neurocrine Biosciences, INC. | $53.74 | 2021 | |
| Boston Scientific Corporation | $49.67 | 2021 | |
| Allergan, INC. | $46.19 | 2020 | |
| Sk Life Science, INC. | $34.09 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $31.39 | 2020 | |
| Mallinckrodt Enterprises LLC | $21.39 | 2019 | |
| Genentech USA, INC. | $21.16 | 2019 | |
| Acorda Therapeutics, INC | $20.34 | 2019 | |
| Livanova USA, INC. | $20.00 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $17.14 | 2020 | |
| Lilly USA, LLC | $16.12 | 2019 | |
| Abbvie INC. | $12.82 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronny Antelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.